Cardiomyopathy Clinical Trial
Official title:
Comparison of Ventricular Fibrillation Induction Techniques During Medtronic Implantable Cardioverter Defibrillator Implant
As the indications for Implantable Cardioverter Defibrillator implantation expand, minimizing
implant time is critical. Also, patients receiving biventricular ICDs are sometimes more
unstable and minimization of sedation time is crucial. Multiple induction attempts, with a
1-Joule shock, can cause disruption in lead position. Therefore limiting the number of
attempts will allow for better lead stability throughout the procedure and a more
straightforward implant process.
Investigator proposes a detailed documentation of success rates from various Ventriculart
Fibrillation induction methods during implant of Medtronic defibrillation capable devices.
Our clinical experience has found that attempts to induce patients receiving ICDs at implant
using the nominal Medtronic T-shock settings are not always effective at inducing ventricular
fibrillation. When this results, a change to the parameters for T-shock is made before
reattempting to induce ventricular fibrillation in patients undergoing ICD implantation.
Another available induction method is 50 Hz Burst. "The 50 Hz Burst induction is designed to
induce VF by delivering a rapid burst of pacing pulses. The amplitude and pulse width of
these pulses are selectable, but the pacing interval is fixed at 20 ms."2 If multiple
attempts using the T-shock method are unsuccessful, 50 Hz Burst provides an additional method
for inducing ventricular fibrillation. It is a less desirable method since it can result in
very fine VF that is difficult to identify the initiation of possibly resulting in longer
times in VF causing higher defibrillation threshold or in undersensing due to the fine nature
of the rhythm.
T-shock has been found to be a fast and reliable method for inducing ventricular fibrillation
in ICD implants. Greater success of inducing ventricular fibrillation using the T-shock
method has been found when the energy of the T-shock was higher and the coupling interval was
shorter. In addition, increasing the shock strength increases the window of vulnerability.
For the T-shock method to be most efficient, initial success at inducing ventricular
fibrillation, and therefore a reduced number of attempts, is important. This requires a
better understanding of the optimal programmed settings for the initial T-shock induction
attempt.
Moreover, in recent years, ICD indications have grown to include primary prevention patients.
These patients may have different vulnerable periods than patients previously evaluated to
develop Medtronic nominal settings.
Our clinical experience has found that the nominal T-shock settings are only effective at
inducing ventricular fibrillation approximately seventy-five percent of the time. However, a
detailed collection of success rates has not been performed.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 | |
Completed |
NCT02892448 -
Cardiac MRI for Metal on Metal Hip Resurfacing
|
N/A | |
Active, not recruiting |
NCT02537782 -
Myocardial Work and Metabolism in CRT
|
N/A | |
Completed |
NCT02525185 -
Contractile Reserve in Dyssynchrony: A Novel Principle to Identify Candidates for Cardiac Resynchronization Therapy
|
||
Terminated |
NCT01705509 -
The Effects of Ranolazine on CPET Parameters in Ischemic Cardiomyopathy Patients (ERIC)
|
N/A | |
Completed |
NCT00999947 -
Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy
|
N/A | |
Completed |
NCT00626028 -
Comparison of Inhaled Nitric Oxide and Oxygen in Participants Reactivity During Acute Pulmonary Vasodilator Testing
|
Phase 3 | |
Recruiting |
NCT00138931 -
Genetics of Cardiovascular and Neuromuscular Disease
|
||
Withdrawn |
NCT02838355 -
Employing End Tidal Capnography in Continuous Flow Ventricular Assist Device Patients
|
N/A | |
Completed |
NCT01085955 -
Investigation in Pregnancy Associate Cardiomyopathy
|
N/A | |
Withdrawn |
NCT00428103 -
Effects of Mitral Valve Repair With the Geoform Ring on Cardiomyopathy
|
N/A | |
Recruiting |
NCT00273637 -
Registry and Survey of Women With Pregnancy Related Cardiomyopathy
|
N/A | |
Completed |
NCT00810550 -
Carotid Ultrasound in the Evaluation of Heart Failure
|
N/A | |
Completed |
NCT04603521 -
Patients' Long-Term Survival of Obstructive Hypertrophic Cardiomyopathy (HCM)
|
||
Enrolling by invitation |
NCT03057561 -
Efficacy of Dotarem® (Gd-DOTA) Versus Gadovist® (Gd-DO3A-butrol) for Late Gadolinium Enhancement Cardiac Magnetic Resonance
|
N/A | |
Completed |
NCT00027170 -
Technical Development of Cardiovascular Magnetic Resonance Imaging
|
||
Not yet recruiting |
NCT02917395 -
Evaluate the Efficacy of Disopyramide Therapy in Hypertrophic Obstructive Cardiomyopathy Patients
|
N/A | |
Completed |
NCT02270840 -
Budapest Upgrade CRT Study (Version 009-4.1)
|
N/A | |
Completed |
NCT02164721 -
Multicenter Automatic Defibrillator Implantation Trial - Chemotherapy-Induced Cardiomyopathy
|
N/A | |
Completed |
NCT02331264 -
Cardiac Assessment of Patients With Hip Implants
|
N/A |